Stay updated on Nivolumab Combinations in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.

Latest updates to the Nivolumab Combinations in Urothelial Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page updates to version v3.2.0, adds the NIH/operating-status notice and a new research citation, and removes the previous v3.0.2 release tag.SummaryDifference2%
- Check25 days agoChange DetectedThe page now emphasizes detailed survival and progression metrics for multiple subgroups (cisplatin-eligible/ineligible, PD-L1 status) with updated results dates and locations; older, broader endpoints and some locations have been removed.SummaryDifference67%
- Check32 days agoChange DetectedNo significant changes detected. The only modification is the removal of the 'Back to Top' link; core content and important details remain unchanged.SummaryDifference0.1%
- Check39 days agoChange DetectedUpdated revision to v3.0.2 and added a Back to Top link; removed the older revision tag.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has been updated to reflect that results have now been submitted, replacing the previous status of no results posted. Additionally, the revision number has been updated to a more specific version.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated to include a comprehensive list of facilities and locations related to a clinical trial, along with a new publication reference. Several previous locations and terms have been removed, streamlining the information presented.SummaryDifference21%
Stay in the know with updates to Nivolumab Combinations in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.